Department of Information Engineering, University of Padova, Padova, Italy.
Diabetes Metab J. 2019 Aug;43(4):383-397. doi: 10.4093/dmj.2019.0121.
By providing blood glucose (BG) concentration measurements in an almost continuous-time fashion for several consecutive days, wearable minimally-invasive continuous glucose monitoring (CGM) sensors are revolutionizing diabetes management, and are becoming an increasingly adopted technology especially for diabetic individuals requiring insulin administrations. Indeed, by providing glucose real-time insights of BG dynamics and trend, and being equipped with visual and acoustic alarms for hypo- and hyperglycemia, CGM devices have been proved to improve safety and effectiveness of diabetes therapy, reduce hypoglycemia incidence and duration, and decrease glycemic variability. Furthermore, the real-time availability of BG values has been stimulating the realization of new tools to provide patients with decision support to improve insulin dosage tuning and infusion. The aim of this paper is to offer an overview of current literature and future possible developments regarding CGM technologies and applications. In particular, first, we outline the technological evolution of CGM devices through the last 20 years. Then, we discuss about the current use of CGM sensors from patients affected by diabetes, and, we report some works proving the beneficial impact provided by the adoption of CGM. Finally, we review some recent advanced applications for diabetes treatment based on CGM sensors.
通过在连续几天内以近乎连续的方式提供血糖 (BG) 浓度测量,可穿戴微创连续血糖监测 (CGM) 传感器正在彻底改变糖尿病管理,并成为一种越来越被采用的技术,特别是对于需要胰岛素治疗的糖尿病患者。事实上,通过提供 BG 动态和趋势的实时葡萄糖洞察,并配备低血糖和高血糖的视觉和声音警报,CGM 设备已被证明可提高糖尿病治疗的安全性和有效性,降低低血糖的发生率和持续时间,并降低血糖变异性。此外,BG 值的实时可用性激发了新工具的实现,为患者提供决策支持,以改善胰岛素剂量调整和输注。本文的目的是概述 CGM 技术和应用的当前文献和未来可能的发展。特别是,首先,我们通过过去 20 年概述了 CGM 设备的技术演变。然后,我们讨论了受糖尿病影响的患者目前对 CGM 传感器的使用情况,并报告了一些证明采用 CGM 提供有益影响的工作。最后,我们回顾了一些基于 CGM 传感器的糖尿病治疗的最新高级应用。